Keith Katkin, Director of Emergent BioSolutions EBS, has filed 1 purchase and 2 sales on the open market. Over the past 12 months that comes to a net sale of $128.2K. The latest trade was on 04/30.

KK

KK

Keith Katkin

Director

Company

Emergent BioSolutions EBS

First filing

23/02/02

Trades

20 trades

Buys / sales

1 / 2

12-month net buying

−$128.2K

Last trade

04/30

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Emergent BioSolutionsEBS	Open-market sale10b5-1 plan	04/30	05/04	15,481 sh	$8.28	$128,182.68	−13.9%
Emergent BioSolutionsEBS	Open-market sale10b5-1 plan	25/05/23	25/05/28	7,844 sh	$6.30	$49,417.2	−8.3%
Syndax PharmaceuticalsSNDX	Open-market buy	25/05/19	25/05/19	10,000 sh	$9.11	$91,100	+11.1%